Ocugen pays $15 mn upfront to Bharat Biotech for Covaxin rights in Canada

Ocugen Inc, the US partner for Bharat Biotech’s Covid-19 vaccine has announced the payment of $ 15 million upfront to the Indian drug maker for extending the vaccine rights to Canada